Breastcancer.org is a nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. Our mission is to help women and their loved ones make sense of the complex medical and personal information about breast cancer, so they can make the best decisions for their lives. Breastcancer.org podcasts offer unique insights on prevention, treatment, research, and other breast cancer topics from our medical experts and invited guests.
Alcohol and Breast Cancer Risk
Dr. Avonne Connor is assistant professor of epidemiology at Johns Hopkins University. Much of Dr. Connor’s research focuses on cancer health disparities in women, especially cancer risk factors that people have some control over, such as drinking alcohol, weight, exercise, and smoking.
Listen to the episode to her Dr. Connor explain:
how much alcohol affects breast cancer risk
why alcohol as a breast cancer risk factor is so emotional
why binge drinking is so harmful
why drinking during treatment isn’t a good idea
steps people can take if they want to reduce or quit drinking
Running time: 24:45
Breast Cancer Research at ESMO 2021
Dr. Brian Wojciechowski practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser. A native of South Philadelphia, he trained at Temple University School of Medicine and Lankenau Medical Center. Dr. Wojciechowski is a sought-after speaker on the topics of medical ethics and the biology of cancer.
Dr. Wojciechowski joined us to talk about some of the most notable research at the European Society for Medical Oncology Congress 2021.
Listen to the episode to hear Dr. Wojciechowski explain:
what an antibody-drug conjugate is
results from the DESTINY-Breast03 study, showing Enhertu more than doubled the 12-month progression-free survival rate compared to Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated
results from the BrighTNess study, showing adding carboplatin to chemotherapy before surgery improves progression-free survival.
Running time: 14:09
Verzenio Reduces Recurrence Risk for Certain Early-Stage Breast Cancers
Dr. Stephen Johnston is professor of breast cancer medicine and consultant medical oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London.
At the European Society for Medical Oncology Virtual Congress 2020, Dr. Johnston presented results from the monarchE trial. This study compared treating people diagnosed with early-stage hormone-receptor-positive, HER2-negative breast cancer with a high risk of recurrence with either standard hormonal therapy after surgery or two years of Verzenio (chemical name: abemaciclib) in addition to standard hormonal therapy.
Listen to the podcast to hear Dr. Johnston explain:
the characteristics that make early-stage hormone-receptor-positive, HER2-negative breast cancer have a high risk of recurrence
an overview of the study and its early results
side effects caused by Verzenio seen in the study
the future of using Verzenio to treat early-stage hormone-receptor-positive, HER2-negative breast cancer with a high risk of recurrence
Running time: 27:08Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, Google Play, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode landing page on our website.
The Importance of Diversity in Breast Cancer Clinical Trials
Dr. Lola Fayanju is the Helen O. Dickens Presidential Associate Professor at the Perelman School of Medicine at the University of Pennsylvania, where she is also chief of breast surgery at Penn Medicine, as well as surgical director of the Rena Rowan Breast Center. Her research focuses on health disparities, aggressive breast cancer variants, and improving value in oncology.
Studies show that overall participation in cancer clinical trials is low, and participation by people of color is even lower. This is thought to be part of the reason that minority women — especially Black women — have worse breast cancer outcomes than white women.
One strategy to help reduce disparities in breast cancer outcomes is to make clinical trials more diverse.
Listen to the podcast to hear Dr. Fayanju explain:
why diversity in clinical trials is important
some of the barriers that keep people of color from enrolling in clinical trials and how they can be overcome
how she talks to all her patients about clinical trials
Running time: 31:11Thank you for listening to the Breastcancer.org Podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, Google Play,
or wherever you listen to podcasts. To share your thoughts about this
or any episode, leave feedback on the podcast episode landing page on
Breast Cancer Inspired Me to Start a Lingerie Company
Dana Donofree is a designer and founder of AnaOno. After being diagnosed with stage I estrogen-receptor-positive, HER2-positive breast cancer almost 10 years ago at the age of 27, Dana began to design her first pieces to meet her need for sexy, beautiful lingerie during a recovery period that she calls “anything but sexy and beautiful.”
She has made it her mission to design lingerie specifically for women who have had breast surgery, breast reconstruction, or are living with other conditions that cause pain because she believes that they shouldn't have to compromise between comfort and beauty.
On February 9, for the fourth year in a row, AnaOno is partnering with #Cancerland to put on a fashion show during New York Fashion Week to raise funds for METAvivor. All the models in the show are women who have been touched in some way by breast cancer or its risk — from previvors to people with early-stage disease to people with stage IV disease — to start new conversations between all these groups.
Listen to the podcast to hear Dana talk about:
her diagnosis and treatment and how it inspired her to start AnaOno
where the AnaOno name came from
the show during Fashion Week and what she hopes to accomplish with it
her tips for someone who has just been diagnosed with breast cancer
Running time: 29:32Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode landing page on our website.
Sexuality and Breast Cancer: Get Your Mojo Back
Because Valentine’s Day is in February, many people start thinking about romance, love, and sex — and their satisfaction with what they have. The February 2014 Breastcancer.org podcast features Lynn Wang, M.D., female sexual medicine specialist for the Main Line Health System and member of the Breastcancer.org Professional Advisory Board. She is a board-certified gynecologist and American Association of Sexuality Educators, Counselors and Therapists-certified counselor and educator. Listen to the podcast to hear Dr. Wang discuss:
different models of female sexual response
the biological, psychological, social, and relationship reasons why libido may be reduced
how a breast cancer diagnosis and treatment can affect libido and sexual satisfaction
who to talk to if you’re having sexual problems
Running time: 29:54 These podcasts, along with all the other vital content and community
support at Breastcancer.org, only exist because of the generous
donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.
This women’s story was very moving and relatable. However, it said that it was going to discuss reconstruction. She had the Diep flap, which I’m leaning b toward, but trying to gather as much info as possible. Unless I missed something, it was never mentioned in the interview. So very disappointed!